Acute reperfusion without recanalization: Serial assessment of collaterals within 6 h of using perfusion-weighted magnetic resonance imaging.


Journal

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
ISSN: 1559-7016
Titre abrégé: J Cereb Blood Flow Metab
Pays: United States
ID NLM: 8112566

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 3 1 2018
medline: 24 12 2019
entrez: 3 1 2018
Statut: ppublish

Résumé

Acute reperfusion despite persistent arterial occlusion may occur in up to 30% of ischemic stroke patients. Recruitment of leptomeningeal collaterals may explain this phenomenon. Using dynamic susceptibility-contrast perfusion imaging (DSC-PI), we assessed acute changes in collateral flow among patients without recanalization. From a multicenter prospective database (I-KNOW), 46 patients with magnetic resonance angiography visible occlusion in whom both reperfusion and recanalization were assessed within 6 h of onset were identified. Maps of collateral flow at arterial, capillary and late venous phases were generated from DSC-PI through inter-frame registration, baseline signal subtraction and temporal summation, and graded blind to all other relevant clinical and radiological data using the Higashida scale. Flow direction and the acute evolution of collaterals were evaluated against the reperfusion status. Among patients without recanalization ( n = 33), flow direction remained retrograde. Collateral grades significantly improved between admission and acute follow-up in patients who reperfused (OR: 4.57; 95% CI: 1.1-22.7; p = 0.048), but not in those without reperfusion (OR: 1.34; 95% CI: 0.4-4.5; p = 0.623). Our study confirmed that acute reperfusion without recanalization is associated with a significant improvement of retrograde collateral flow. DSC-PI can detect acute changes in collateral flow, and may help evaluate novel treatments targeting leptomeningeal collaterals.

Identifiants

pubmed: 29291673
doi: 10.1177/0271678X17744716
pmc: PMC6365601
doi:

Types de publication

Clinical Trial Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

251-259

Références

Radiology. 2015 May;275(2):510-20
pubmed: 25633505
Radiology. 2013 Oct;269(1):240-8
pubmed: 23716707
Stroke. 2013 Aug;44(8):2318-20
pubmed: 23723309
Stroke. 2003 Aug;34(8):e109-37
pubmed: 12869717
Eur J Neurol. 2013 May;20(5):795-802
pubmed: 23278976
J Cereb Blood Flow Metab. 2012 Dec;32(12):2091-9
pubmed: 23047270
Brain. 2013 Dec;136(Pt 12):3554-60
pubmed: 24065722
Eur Radiol. 2017 Feb;27(2):618-626
pubmed: 27221558
Lancet Neurol. 2012 Oct;11(10):860-7
pubmed: 22954705
Neurology. 2016 Feb 2;86(5):434-41
pubmed: 26740681
Ann Neurol. 2014 Sep;76(3):356-69
pubmed: 24985162
Stroke. 2015 Jun;46(6):1582-9
pubmed: 25908463
Brain. 2011 Jun;134(Pt 6):1765-76
pubmed: 21616971
J Cereb Blood Flow Metab. 2013 Aug;33(8):1168-72
pubmed: 23652626
Stroke. 2013 Aug;44(8):2194-9
pubmed: 23760216
Stroke. 2014 Mar;45(3):759-64
pubmed: 24473178
Eur Radiol. 2016 May;26(5):1396-403
pubmed: 26210207
Stroke. 2015 Oct;46(10):2800-7
pubmed: 26306754
Stroke. 2005 Nov;36(11):2400-3
pubmed: 16224088
Psychometrika. 1947 Jun;12(2):153-7
pubmed: 20254758
Stroke. 2011 Aug;42(8):2235-9
pubmed: 21737798
Sci Rep. 2016 Jun 14;6:27880
pubmed: 27296511
Magn Reson Med. 2003 Jul;50(1):164-74
pubmed: 12815691
Stroke. 2010 Jan;41(1):e34-40
pubmed: 19910542
Ann Neurol. 2007 Jun;61(6):533-43
pubmed: 17431875
Stroke. 2011 Mar;42(3):693-9
pubmed: 21233472
Stroke. 2009 Aug;40(8):2872-4
pubmed: 19478228
Brain. 2009 Aug;132(Pt 8):2231-8
pubmed: 19509116
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
AJNR Am J Neuroradiol. 2011 Oct;32(9):1640-5
pubmed: 21799045
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
J Cereb Blood Flow Metab. 2015 Feb;35(2):206-12
pubmed: 25370859
Stroke. 2010 Oct;41(10):2316-22
pubmed: 20829514

Auteurs

Nikolaos Makris (N)

1 Department of Stroke Medicine and Department of Neuroradiology, Université Lyon 1, CREATIS, CNRS UMR 5220-INSERM U1206, INSA-Lyon; Hospices Civils de Lyon, Lyon, France.

Leila Chamard (L)

1 Department of Stroke Medicine and Department of Neuroradiology, Université Lyon 1, CREATIS, CNRS UMR 5220-INSERM U1206, INSA-Lyon; Hospices Civils de Lyon, Lyon, France.

Irene K Mikkelsen (IK)

2 Center of Functionally Integrative Neuroscience, Aarhus University, Aarhus, Denmark.

Marc Hermier (M)

1 Department of Stroke Medicine and Department of Neuroradiology, Université Lyon 1, CREATIS, CNRS UMR 5220-INSERM U1206, INSA-Lyon; Hospices Civils de Lyon, Lyon, France.

Laurent Derex (L)

1 Department of Stroke Medicine and Department of Neuroradiology, Université Lyon 1, CREATIS, CNRS UMR 5220-INSERM U1206, INSA-Lyon; Hospices Civils de Lyon, Lyon, France.

Salvador Pedraza (S)

3 Department of Radiology (IDI), Girona Biomedical Research Institute (IDIBGI), Hospital Universitari de Girona Dr Josep Trueta, Girona, Spain.

Götz Thomalla (G)

4 Department of Neurology, Head and Neuro Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Leif Østergaard (L)

2 Center of Functionally Integrative Neuroscience, Aarhus University, Aarhus, Denmark.

Jean-Claude Baron (JC)

5 University of Cambridge, Department of Clinical Neurosciences, Cambridge, UK; INSERM U894, Hôpital Sainte-Anne, Université Paris Descartes, Paris, France.

Norbert Nighoghossian (N)

1 Department of Stroke Medicine and Department of Neuroradiology, Université Lyon 1, CREATIS, CNRS UMR 5220-INSERM U1206, INSA-Lyon; Hospices Civils de Lyon, Lyon, France.

Yves Berthezène (Y)

1 Department of Stroke Medicine and Department of Neuroradiology, Université Lyon 1, CREATIS, CNRS UMR 5220-INSERM U1206, INSA-Lyon; Hospices Civils de Lyon, Lyon, France.

Tae-Hee Cho (TH)

1 Department of Stroke Medicine and Department of Neuroradiology, Université Lyon 1, CREATIS, CNRS UMR 5220-INSERM U1206, INSA-Lyon; Hospices Civils de Lyon, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH